A 500-MHz proton nuclear magnetic resonance study of mu opioid peptides in a simulated receptor environment. 1987

M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
Dipartimento di Chimica, Università di Napoli, Italy.

The structure-activity relationship of several mu selective opioid peptides has been evaluated on the basis of both experimental and theoretical approaches. The conformations of Tyr-D-Ala-Phe-Gly-NH2, the tetrapeptide N-fragment of dermorphin, and two analogues have been studied in solution by 1H NMR spectroscopy. The physicochemical environment inside the receptor has been simulated by complexing the peptides with a crown ether and dissolving the complexes in chloroform. The family of conformations derived from the NMR data possesses most of the features previously proposed for mu agonists and is fully consistent with an original model of the mu receptor based on the structures of many rigid opiates. As a simple test of this model, the synthesis of a linear peptide with significant mu activity in spite of the absence of Tyr1 is reported.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017450 Receptors, Opioid, mu A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. Morphine Receptors,Opioid Receptors, mu,Receptors, Morphine,Receptors, mu,Receptors, mu Opioid,mu Receptors,Morphine Receptor,mu Opioid Receptor,mu Receptor,Opioid Receptor, mu,Receptor, Morphine,Receptor, mu,Receptor, mu Opioid,mu Opioid Receptors

Related Publications

M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
December 1987, Biochemistry,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
April 1984, European journal of biochemistry,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
March 1969, Nature,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
April 1983, Biochemistry,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
August 1984, Biochemistry,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
June 1984, Biochemical and biophysical research communications,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
December 1981, Biochemistry,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
October 1989, Biochemistry,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
September 1982, European journal of biochemistry,
M A Castiglione-Morelli, and F Lelj, and A Pastore, and S Salvadori, and T Tancredi, and R Tomatis, and E Trivellone, and P A Temussi
May 1987, FEBS letters,
Copied contents to your clipboard!